What Is Treatment-Emergent Central Sleep Apnea (TECSA)?
At a Glance
Treatment-emergent central sleep apnea (TECSA) happens when CPAP therapy clears your airway, causing a drop in CO2 that temporarily pauses your brain's breathing signals. For most people, this complex sleep apnea resolves on its own within 4 to 8 weeks of consistent CPAP use.
In this answer
4 sections
Starting CPAP therapy is a big step toward better sleep and health. However, some patients are surprised to learn that their sleep apnea has “changed” after starting treatment. You might discover this during a follow-up appointment, or you might wake up, check your CPAP app (like MyAir), and panic when you see a spike in “Clear Airway” or “Central” events.
If your doctor or machine data indicates that you developed treatment-emergent central sleep apnea (TECSA)—sometimes called complex sleep apnea—it is natural to feel confused or worried.
Understanding why this happens can help alleviate those fears. This condition is actually a known response to positive airway pressure therapy and, for many people, it is just a temporary adjustment period.
The Different Types of Sleep Apnea
To understand TECSA, it helps to distinguish between the three primary ways sleep apnea can occur:
- Obstructive Sleep Apnea (OSA): A physical problem. The muscles in your throat relax, causing the airway to collapse and block airflow while you sleep. Your brain is trying to breathe, but the air cannot get through.
- Central Sleep Apnea (CSA): A neurological problem. Your airway is completely open, but the brain temporarily “forgets” or fails to send the signal to your respiratory muscles to take a breath.
- Mixed Sleep Apnea: A combination of both physical obstruction and a lack of breathing effort.
Why Does CPAP Cause Central Sleep Apnea?
When you start using a CPAP machine, the continuous pressure successfully acts as a splint, keeping your physical airway completely open [1][2].
Because your airway is now clear, you suddenly start breathing much more efficiently than your body is used to. This sudden increase in airflow can cause a rapid drop in the carbon dioxide (CO2) levels in your blood [3][4].
Your brain relies on a certain level of CO2 to trigger the natural urge to breathe. When the CPAP machine clears the obstruction and your CO2 drops below that threshold, the brain’s respiratory center essentially pauses and thinks, “We have plenty of oxygen and not enough CO2, we don’t need to breathe right now” [3][4]. This creates a central apnea—a pause in breathing driven by the brain rather than a blocked throat.
This phenomenon of central apneas emerging or persisting once obstructive events are treated is what doctors call treatment-emergent central sleep apnea [1][5]. It happens to roughly 8% of patients who begin CPAP therapy for obstructive sleep apnea [6][7].
Will It Go Away?
For the vast majority of patients, TECSA is a dynamic, temporary process that typically resolves on its own within 4 to 8 weeks [7]. As you continue to use your CPAP machine night after night, your brain and body gradually recalibrate to normal, healthy oxygen and CO2 levels [7].
Because spontaneous resolution is so common, the standard initial approach is often “expectant management” [7]. This means you continue your CPAP therapy while your doctor closely monitors your progress, often by reviewing your machine’s data remotely. It is crucial not to stop using your machine during this adjustment period, and try not to obsess over your morning app scores while your body is still adapting.
What If It Persists?
While many cases resolve on their own, a minority of patients will continue to experience central apneas [7]. If your “Central” or “Clear Airway” events do not go away after 4 to 8 weeks, or if you are experiencing severe daytime sleepiness and fatigue that makes it hard to function, it is time to contact your doctor. They have several options:
- Adjusting CPAP settings: Sometimes lowering the pressure or switching to a different pressure mode can help stabilize your breathing [8].
- Alternative machines: Your doctor might switch you to a more advanced machine, such as a BiPAP (Bilevel Positive Airway Pressure) or an ASV (Adaptive Servo-Ventilation) machine [9][8]. ASV devices specifically track your breathing rhythm and automatically adjust the pressure to stabilize your breathing pattern [9]. Note: ASV therapy is contraindicated and unsafe for patients with certain types of heart failure (such as heart failure with reduced ejection fraction), so your doctor will review your cardiac history before prescribing this option [10][11].
- Supplemental oxygen or medication: In some cases, adding oxygen or prescribing specific respiratory-stimulating medications can help regulate your breathing drive [7][12].
The appearance of complex sleep apnea does not mean CPAP has failed you. It simply means your body is adjusting to a clear airway, and you and your care team may need to fine-tune your treatment to find the perfect balance.
Common questions in this guide
Why does my CPAP app show high 'clear airway' or 'central' events?
Will treatment-emergent central sleep apnea go away on its own?
What should I do if my complex sleep apnea does not improve?
Can anyone with complex sleep apnea use an ASV machine?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How often will you be reviewing my machine data remotely during this adjustment period?
- 2.If my 'Central' or 'Clear Airway' events don't decrease after 4 to 8 weeks, at what point should we discuss lowering my pressure?
- 3.How long should we wait before considering a change to a different device, like an ASV or BiPAP machine?
- 4.Do I have any underlying heart conditions, like heart failure, that would limit my options for advanced machines like ASV?
- 5.Are there any other data points from my machine, like mask leak rates, that might be contributing to these central apneas?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
The prevalence and polysomnographic characteristics of treatment-emergent central sleep apnea with obstructive sleep apnea.
Berik Safçi S
Sleep & breathing = Schlaf & Atmung 2024; (28(3)):1245-1250 doi:10.1007/s11325-024-02999-1.
PMID: 38308750 - 2
Complex sleep apnea at auto-titrating CPAP initiation: prevalence, significance and predictive factors.
Neu D, Balkissou AD, Mairesse O, et al.
The clinical respiratory journal 2017; (11(2)):200-209 doi:10.1111/crj.12325.
PMID: 26072986 - 3
Clinical Use of Loop Gain Measures to Determine Continuous Positive Airway Pressure Efficacy in Patients with Complex Sleep Apnea. A Pilot Study.
Stanchina M, Robinson K, Corrao W, et al.
Annals of the American Thoracic Society 2015; (12(9)):1351-7 doi:10.1513/AnnalsATS.201410-469BC.
PMID: 26214564 - 4
3-minute central apneas: enhanced expiratory rebreathing space to the rescue.
Wojnowski K, Primera G, Johnson KG
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2025; (21(6)):1133-1137 doi:10.5664/jcsm.11582.
PMID: 40012298 - 5
Central sleep apnoea-a clinical review.
Muza RT
Journal of thoracic disease 2015; (7(5)):930-7 doi:10.3978/j.issn.2072-1439.2015.04.45.
PMID: 26101651 - 6
A systematic review on prevalence and risk factors associated with treatment- emergent central sleep apnea.
Nigam G, Pathak C, Riaz M
Annals of thoracic medicine 2016; (11(3)):202-10 doi:10.4103/1817-1737.185761.
PMID: 27512510 - 7
Treatment-Emergent Central Apnea: Physiologic Mechanisms Informing Clinical Practice.
Zeineddine S, Badr MS
Chest 2021; (159(6)):2449-2457 doi:10.1016/j.chest.2021.01.036.
PMID: 33497650 - 8
Treatments for obstructive sleep apnea: CPAP and beyond.
Aboussouan LS, Bhat A, Coy T, Kominsky A
Cleveland Clinic journal of medicine 2023; (90(12)):755-765 doi:10.3949/ccjm.90a.23032.
PMID: 38040437 - 9
Sleep-Related Breathing Disorders: When CPAP Is Not Enough.
Selim B, Ramar K
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021; (18(1)):81-90 doi:10.1007/s13311-020-00955-x.
PMID: 33150546 - 10
Sleep-disordered breathing in heart failure: The state of the art after the SERVE-HF trial.
Carmo J, Araújo I, Marques F, Fonseca C
Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2017; (36(11)):859-867 doi:10.1016/j.repc.2017.06.007.
PMID: 29162360 - 11
Reply on behalf of the European Respiratory Society and European Sleep Research Society task force.
Randerath W, Schiza S, Arzt M, Schwarz EI
The European respiratory journal 2026; (67(3)) doi:10.1183/13993003.02729-2025.
PMID: 41786488 - 12
Treatment-emergent central sleep apnoea managed by CPAP with adjunctive acetazolamide: A case report.
Kwok CT, Wong KC, Kwok CL, et al.
Respirology case reports 2022; (10(4)):e0916 doi:10.1002/rcr2.916.
PMID: 35251664
This page explains complex sleep apnea for educational purposes and does not replace professional medical advice. Always contact your sleep specialist if you have concerns about your CPAP machine data or experience severe daytime fatigue.
Get notified when new evidence is published on Sleep Apnea.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.